Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
Go back to Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics| Sernova Corp Common Shares (AMEX: SEOVF) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $0.31 | |||
| Open | $0.09 | 52 Week Low | $0.16 | |||
| Day High | $0.09 | P/E | N/A | |||
| Day Low | $0.09 | EPS | $0.00 | |||
| Volume | 78,979 | |||||
| Sinovac Biotech, Ltd (NASDAQ: SVA) | Delayed: 6.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.47 | 52 Week High | $7.16 | |||
| Open | $0.08 | 52 Week Low | $4.38 | |||
| Day High | $6.47 | P/E | N/A | |||
| Day Low | $6.47 | EPS | $-0.08 | |||
| Volume | 39,200 | |||||



